AMF Pensionsforsakring AB held its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 537,308 shares of the medical research company’s stock at the end of the second quarter. Thermo Fisher Scientific makes up 0.9% of AMF Pensionsforsakring AB’s holdings, making the stock its 26th largest position. AMF Pensionsforsakring AB’s holdings in Thermo Fisher Scientific were worth $82,531,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. increased its position in shares of Thermo Fisher Scientific by 2.7% in the first quarter. Vanguard Group Inc. now owns 25,971,301 shares of the medical research company’s stock worth $3,989,193,000 after buying an additional 695,079 shares in the last quarter. BlackRock Inc. increased its position in shares of Thermo Fisher Scientific by 2,692.1% in the first quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock worth $3,531,095,000 after buying an additional 22,165,530 shares in the last quarter. State Street Corp increased its stake in shares of Thermo Fisher Scientific by 1.0% in the first quarter. State Street Corp now owns 16,085,954 shares of the medical research company’s stock valued at $2,470,802,000 after buying an additional 164,367 shares during the period. Wellington Management Group LLP increased its stake in shares of Thermo Fisher Scientific by 5.6% in the first quarter. Wellington Management Group LLP now owns 7,512,152 shares of the medical research company’s stock valued at $1,153,867,000 after buying an additional 398,622 shares during the period. Finally, Morgan Stanley increased its stake in shares of Thermo Fisher Scientific by 7.6% in the first quarter. Morgan Stanley now owns 4,664,882 shares of the medical research company’s stock valued at $716,526,000 after buying an additional 327,826 shares during the period. 87.60% of the stock is owned by institutional investors and hedge funds.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) traded up 0.32% during midday trading on Monday, reaching $173.78. 526,737 shares of the company traded hands. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $182.87. The company has a 50 day moving average price of $176.78 and a 200 day moving average price of $165.46. The company has a market capitalization of $67.79 billion, a PE ratio of 30.28 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.92 billion. During the same quarter in the prior year, the business posted $2.03 EPS. Thermo Fisher Scientific’s revenue for the quarter was up 10.2% compared to the same quarter last year. On average, analysts expect that Thermo Fisher Scientific Inc will post $9.24 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be paid a dividend of $0.15 per share. The ex-dividend date is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a yield of 0.35%. Thermo Fisher Scientific’s payout ratio is 10.45%.

COPYRIGHT VIOLATION NOTICE: “AMF Pensionsforsakring AB Maintains Stake in Thermo Fisher Scientific Inc (TMO)” was originally reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.watchlistnews.com/amf-pensionsforsakring-ab-maintains-stake-in-thermo-fisher-scientific-inc-tmo/1486970.html.

Several equities research analysts recently weighed in on the stock. Bank of America Corporation raised their price target on shares of Thermo Fisher Scientific from $190.00 to $200.00 and gave the company a “buy” rating in a research report on Tuesday, May 9th. Cleveland Research raised shares of Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Jefferies Group LLC raised their price target on shares of Thermo Fisher Scientific from $160.00 to $175.00 and gave the company a “hold” rating in a research report on Friday, April 28th. BidaskClub downgraded shares of Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 27th. Finally, Citigroup Inc. reissued a “buy” rating and set a $201.00 price target (up previously from $182.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 10th. One analyst has rated the stock with a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $188.56.

In other news, CFO Stephen Williamson sold 2,500 shares of the stock in a transaction on Monday, June 5th. The shares were sold at an average price of $176.26, for a total value of $440,650.00. Following the sale, the chief financial officer now owns 37,790 shares in the company, valued at $6,660,865.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Daniel P. Shine sold 4,688 shares of the stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $171.88, for a total transaction of $805,773.44. Following the completion of the sale, the insider now owns 29,200 shares in the company, valued at approximately $5,018,896. The disclosure for this sale can be found here. Insiders have sold a total of 27,188 shares of company stock worth $4,702,223 in the last 90 days. 0.49% of the stock is currently owned by company insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.